Not sure I agree, but I certainly would not place a bulk of the blame or causation on the suggestion of international VOL transfer. The V2TX is quite robust in participation as I also participate in the international VOL trade. Equity dispersion being as high as they have been and volatility correlations being as low as they have been, as an…[Read more]

How would you describe the leverage risk employed with that participation vs. leveraged ETPs. Would be beneficial to describe for onlookers and other potential participants.

That’s doable. The issue is still the price, the CMA approval, reimbursement billing codes etc. Without all of that, the cost is too prohibitive to the consumer and they will rely on the already existing medical grade products that are supported in the healthcare industry.

Hahaha, kind of true. The reality though is that while the Apple Watch makes for a lot of headlines, they don’t even sell 10% of the amount of iPhones. Still an afterthought amongst the consumer crowd. And the incremental cost for that EKG-type application…we’ll see!

given how far and for how long the rubber band has stretched on VVIX, it wouldn’t take much to snap back. Having said that, the catalyst would be…? That’s the question.

Yea, took me some time to learn the platform as well.

something is better than nothing. I’m hoping for a little more VOL near term. Need a fear monger-driven headline to come around in order to detract the markets momentum. But in the meantime, core holdings continue to gobble up decay.